EBiSC

EBiSC

Details

DC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (4 days ago)
RT @EU_ToxRisk: Next week, @EU_ToxRisk workshop open to experts with interest and background into #regulatory science. Focus: regulatory as…
Edelweiss Connect (4 days ago)
Our May 2019 newsletter highlights the upcoming @openrisknet webinars, the May 21-22 free training on New Approach… https://t.co/eYqFaD51iA
Edelweiss Connect (2 weeks ago)
Rich metadata for richer results - learn how AI approaches are increasing the need for rich metadata:… https://t.co/Aj68GoQYTI
Edelweiss Connect (3 weeks ago)
RT @barryhardy: Automated & Integrated Workflow for Adverse Outcome Pathway Identification, Hypothesis Generation & Risk Assessment, Webina…
Edelweiss Connect (3 weeks ago)
RT @KristiePCRM: Still a few in-person spots left for the May 21-22 New Approach Methodologies #invitro #computational #toxicology training…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 633 29 78
  • Email: info@edelweissconnect.com

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA
  • Phone: +1 252 654 9003
  • Email: info@edelweissconnect.com